The presentation of gastrointestinal (GI) illnesses is similar in patients with end-stage kidney disease (ESKD) and in the general population. However, there are several instances where kidney failure and renal replacement therapy (RRT) can affect the course of the disease and its management. In this section, we will focus on unique factors of GI illnesses that should be considered in the ESKD population with and without residual kidney function (RKF). We will also discuss the role of RRT modalities in the occurrence and treatment of GI disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/sdi.12874 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!